<DOC>
	<DOCNO>NCT00271401</DOCNO>
	<brief_summary>The purpose study compare effectiveness safety intracoronary stenting without abciximab , anti-platelet therapy , conventional coronary angioplasty abciximab patient undergo percutaneous coronary intervention .</brief_summary>
	<brief_title>A Study Comparing Efficacy Safety Intracoronary Stenting With Without Abciximab , Anti-Platelet Therapy , Conventional Coronary Angioplasty With Abciximab</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , placebo-controlled study evaluate safety effectiveness intracoronary stenting without abciximab , anti-platelet therapy , conventional coronary angioplasty abciximab patient undergo percutaneous coronary intervention . Patients randomly assign one three treatment group : coronary angioplasty plus abciximab , intracoronary stent plus abciximab , intracoronary stent plus placebo . The primary measure effectiveness 30-day composite , clinical outcome determine number death , myocardial infarction , urgent repeat revascularizations . Please see attached result . Patients receive one three different treatment : Coronary angioplasty plus abciximab ; Intracoronary stent plus abciximab ; Intracoronary stent plus placebo .</detailed_description>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<criteria>Patients refer elective urgent percutaneous coronary intervention Who suitable candidate either conventional angioplasty primary intracoronary stent implantation Having target artery ( native graft ) stenosis &gt; = 60 % ( visual estimation ) Patients acute STsegment elevation myocardial infarction within previous 12 hour With plan staged procedure unprotected leave main coronary artery stenosis &gt; 50 % With active internal bleeding , condition may increase risk bleeding , receive ongoing treatment oral anticoagulant time study entry Having percutaneous coronary intervention within previous 3 month prior intracoronary stent placement target vessel Having hypertension systolic blood pressure &gt; 180 mm Hg diastolic blood pressure &gt; 100 mm Hg time study entry , platelet count &lt; 100,000/Î¼L baseline</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Stents</keyword>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
</DOC>